IJMS, Vol. 18, Pages 1606: The Role of Epigenetic Regulation in Epstein-Barr Virus-Associated Gastric Cancer

IJMS, Vol. 18, Pages 1606: The Role of Epigenetic Regulation in Epstein-Barr Virus-Associated Gastric Cancer

International Journal of Molecular Sciences doi: 10.3390/ijms18081606

Authors: Jun Nishikawa Hisashi Iizasa Hironori Yoshiyama Munetaka Nakamura Mari Saito Sho Sasaki Kanami Shimokuri Masashi Yanagihara Kouhei Sakai Yutaka Suehiro Takahiro Yamasaki Isao Sakaida

The Epstein–Barr virus (EBV) is detected in about 10% of gastric carcinoma cases throughout the world. In EBV-associated gastric carcinoma (EBVaGC), all tumor cells harbor the clonal EBV genome. The expression of latent EBV genes is strictly regulated through the methylation of EBV DNA. The methylation of viral DNA regulates the type of EBV latency, and methylation of the tumor suppressor genes is a key abnormality in EBVaGC. The methylation frequencies of several tumor suppressor genes and cell adhesion molecules are significantly higher in EBVaGC than in control cases. EBV-derived microRNAs repress translation from viral and host mRNAs. EBV regulates the expression of non-coding RNA in gastric carcinoma. With regard to the clinical application of demethylating agents against EBVaGC, we investigated the effects of decitabine against the EBVaGC cell lines. Decitabine inhibited the cell growth of EBVaGC cells. The promoter regions of p73 and Runt-related transcription factor 3(RUNX3) were demethylated, and their expression was upregulated by the treatment. We review the role of epigenetic regulation in the development and maintenance of EBVaGC and discuss the therapeutic application of DNA demethylating agents for EBVaGC.

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2uV5xPs
via IFTTT